Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

INSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICER
  • USA - English

Insightec Logo (PRNewsfoto/Insightec)

News provided by

Insightec

03 Sep, 2024, 20:16 IDT

Share this article

Share toX

Share this article

Share toX

HAIFA, Israel and MIAMI, Sept. 3, 2024 /CNW/ -- Insightec, a global healthcare company dedicated to using focused ultrasound to transform patient care, today announced the appointment of Jake Ghannam as Chief Commercial Officer. In this new role, Ghannam will be responsible for leading commercial operations, driving growth, and spearheading market strategies across global markets.

Continue Reading
Jake Ghannam
Jake Ghannam

With an impressive track record, Ghannam brings his expertise in strategic planning and business development to Insightec. His leadership is expected to bolster Insightec's mission of advancing patient care through cutting-edge technologies and solutions.

"At Insightec, we are committed to transforming the paradigm of healthcare with focused ultrasound," said Maurice R. Ferré, M.D., chief executive officer and chairman of the board. "Jake's deep understanding of the sector, combined with his passion for innovation, makes him the perfect fit to lead our commercial strategy and accelerate growth."

Ghannam joins Insightec following time spent at Medtronic and GE HealthCare, where he spearheaded business expansion and innovation initiatives. His impressive track record of success is matched only by his passion for customer-centric solutions.

"I am thrilled to join Insightec at such an exciting time," said Ghannam. "Innovation in healthcare isn't just about breakthroughs – it's about reshaping what's possible. I look forward to leading our talented team, driving innovation, and delivering solutions that make a real difference in patients' lives."

About Insightec

Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson's disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo.

Follow us on Facebook, LinkedIn and Twitter or visit www.insightec.com for more information.

Forward-looking Statements:

This document contains forward-looking statements regarding, among other things, plans, expectations, and future events. In some cases, forward-looking statements can be identified by the following words: "may," "can," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "promise," "continue," "ongoing," or the negative of these terms. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Insightec as of the date of the statement. All written or oral forward-looking statements attributable to Insightec are qualified by this caution. Insightec does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Insightec's expectations.

"Exablate," and "Exablate Neuro," as well as the "INSIGHTEC" logo, whether standing alone or in connection with the word "Insightec," are protected trademarks of Insightec.

Photo - https://mma.prnewswire.com/media/2495225/Jake_Ghannam.jpg
Logo - https://mma.prnewswire.com/media/1699588/4888797/Insightec_Logo.jpg

SOURCE Insightec

Modal title

Also from this source

Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor

Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor

Insightec, a global healthcare innovator pioneering the use of focused ultrasound to transform patient care, today announced that Lord Julian...

Insightec Announces FDA Approval of Staged Bilateral Focused Ultrasound Treatment for Parkinson's Disease

Insightec Announces FDA Approval of Staged Bilateral Focused Ultrasound Treatment for Parkinson's Disease

Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and Drug ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Computer & Electronics

Computer & Electronics

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.